This paper updates the mortality cost of expenditures. Because changes in income lead to changes in mortality risk, regulatory expenditures costing more per life saved than a threshold cost-per-life saved cutoff level are expected to increase mortality risk. This article discusses the mechanisms...

The cost of end-of-life health care is currently the subject of enormous political, academic, and social debate. Sure, this was big news back in the early 1980s, when both Alan Greenspan and Governor Richard Lamm famously articulated the need to limit medical care of the elderly. But three...

Americans are engaged in an earnest and profound debate about how to best manage legal and medical risks at the end of life. This brief Article is an introduction to a written Symposium and a full day of live presentations that not only advance the ongoing debate but also offer a number of fresh...

Governments worldwide are increasingly concerned about the booming CBD (cannabidiol) products. However, little is known about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using...

Fee equalization in health care brings under a unique tariff several medical treatments, coded under different Diagnosis Related Groups (DRGs). The aim is to improve healthcare quality and efficiency by discouraging unnecessary, but better-paid, treatments. We evaluate its effectiveness on...

A versão em português deste texto está disponível em: "http://ssrn.com/abstract=2441607" http://ssrn.com/abstract=2441607 La versione italiana di questo documento è disponibile all'indirizzo: "http://ssrn.com/abstract=2607031" http://ssrn.com/abstract=2607031La versión en español de este...

The medical community often argues that physician fear of legal liability increases health care spending. Theoretically, though, the effect could be positive or negative, and empirical evidence has supported both cases. Previous empirical work, however, has ignored the fact that physicians face...

High specialty drug prices have spawned an ecosystem of financial and behavioral support services for specialty drugs, including copay support, reimbursement coordination, and nursing support intended to improve drug adherence. Increasingly, these services are bundled together in drug...

Specialty drugs, often dispensed by specialty pharmacies, are among the most expensive drugs on the market. They are significant contributors to the American health care cost problem, but in many ways they escape public and regulatory scrutiny. Surprisingly, medications are designated as...

Policymakers on both ends of the political spectrum have been looking for ways to reduce prescription drug prices. Democrats have also been working on expanding healthcare coverage, including different versions of Medicare for All. All these proposals have been framed as issues of access and...